Inflammation: the link between comorbidities, genetics, and Alzheimer's disease
EA Newcombe, J Camats-Perna, ML Silva… - Journal of …, 2018 - Springer
Alzheimer's disease (AD) is a neurodegenerative disorder, most cases of which lack a clear
causative event. This has made the disease difficult to characterize and, thus, diagnose …
causative event. This has made the disease difficult to characterize and, thus, diagnose …
Tachykinins and their receptors: contributions to physiological control and the mechanisms of disease
MS Steinhoff, B von Mentzer, P Geppetti… - Physiological …, 2014 - journals.physiology.org
The tachykinins, exemplified by substance P, are one of the most intensively studied
neuropeptide families. They comprise a series of structurally related peptides that derive …
neuropeptide families. They comprise a series of structurally related peptides that derive …
Activation of mast-cell-expressed mas-related G-protein-coupled receptors drives non-histaminergic itch
J Meixiong, M Anderson, N Limjunyawong… - Immunity, 2019 - cell.com
Classical itch studies have focused on immunoglobulin E (IgE)-mediated mast cell activation
and histamine release. Recently, members of the Mas-related G-protein-coupled receptor …
and histamine release. Recently, members of the Mas-related G-protein-coupled receptor …
Neuronal control of skin function: the skin as a neuroimmunoendocrine organ
D Roosterman, T Goerge, SW Schneider… - Physiological …, 2006 - journals.physiology.org
This review focuses on the role of the peripheral nervous system in cutaneous biology and
disease. During the last few years, a modern concept of an interactive network between …
disease. During the last few years, a modern concept of an interactive network between …
Mast cells, neuroinflammation and pain in fibromyalgia syndrome
Fibromyalgia Syndrome (FMS) is a disorder of chronic, generalized muscular pain,
accompanied by sleep disturbances, fatigue and cognitive dysfunction. There is no definitive …
accompanied by sleep disturbances, fatigue and cognitive dysfunction. There is no definitive …
[HTML][HTML] TRPA1 controls inflammation and pruritogen responses in allergic contact dermatitis
B Liu, J Escalera, S Balakrishna, L Fan… - The FASEB …, 2013 - ncbi.nlm.nih.gov
Allergic contact dermatitis is a common skin disease associated with inflammation and
persistent pruritus. Transient receptor potential (TRP) ion channels in skin-innervating …
persistent pruritus. Transient receptor potential (TRP) ion channels in skin-innervating …
Modern aspects of cutaneous neurogenic inflammation
M Steinhoff, S Ständer, S Seeliger… - Archives of …, 2003 - jamanetwork.com
Recent findings have shed new light on the role of peripheral nerves in the skin and
established a modern concept of cutaneous neurobiology. Closely related monodirectional …
established a modern concept of cutaneous neurobiology. Closely related monodirectional …
Fibroblasts—a diverse population at the center of it all
JM Sorrell, AI Caplan - International review of cell and molecular biology, 2009 - Elsevier
The capacity of fibroblasts to produce and organize the extracellular matrix and to
communicate with other cells makes them a central component of tissue biology. Even so …
communicate with other cells makes them a central component of tissue biology. Even so …
Quercetin is more effective than cromolyn in blocking human mast cell cytokine release and inhibits contact dermatitis and photosensitivity in humans
Mast cells are immune cells critical in the pathogenesis of allergic, but also inflammatory and
autoimmune diseases through release of many pro-inflammatory cytokines such as IL-8 and …
autoimmune diseases through release of many pro-inflammatory cytokines such as IL-8 and …
Long-term neprilysin inhibition—implications for ARNIs
DJ Campbell - Nature Reviews Cardiology, 2017 - nature.com
Neprilysin has a major role in both the generation and degradation of bioactive peptides.
LCZ696 (valsartan/sacubitril, Entresto), the first of the new ARNI (dual-acting angiotensin …
LCZ696 (valsartan/sacubitril, Entresto), the first of the new ARNI (dual-acting angiotensin …